- Home
- HCC vs ICUCW Comparison
HCC vs ICUCW Comparison
Compare HCC & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCC | ICUCW |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | 18 |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | N/A |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HCC | ICUCW |
|---|---|---|
| Price | $88.10 | $0.01 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $74.50 | N/A |
| AVG Volume (30 Days) | ★ 786.1K | N/A |
| Earning Date | 11-05-2025 | N/A |
| Dividend Yield | ★ 0.37% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $1,224,320,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.92 | N/A |
| P/E Ratio | $130.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $38.00 | N/A |
| 52 Week High | $89.06 | N/A |
Technical Indicators
Market Signals| Indicator | HCC | ICUCW |
|---|---|---|
| Relative Strength Index (RSI) | 70.04 | 37.08 |
| Support Level | $78.00 | $0.01 |
| Resistance Level | $85.40 | $0.01 |
| Average True Range (ATR) | 3.42 | 0.00 |
| MACD | 0.26 | 0.00 |
| Stochastic Oscillator | 88.92 | 20.00 |
Price Performance
Historical ComparisonAbout HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.